Nadia Rondi

414 total citations
17 papers, 339 citations indexed

About

Nadia Rondi is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Nadia Rondi has authored 17 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Nadia Rondi's work include Colorectal and Anal Carcinomas (12 papers), Colorectal Cancer Surgical Treatments (6 papers) and Gastric Cancer Management and Outcomes (4 papers). Nadia Rondi is often cited by papers focused on Colorectal and Anal Carcinomas (12 papers), Colorectal Cancer Surgical Treatments (6 papers) and Gastric Cancer Management and Outcomes (4 papers). Nadia Rondi collaborates with scholars based in Italy, Belarus and Russia. Nadia Rondi's co-authors include Umberto Ricardi, Pierfrancesco Franco, Francesca Arcadipane, Mario Morino, Riccardo Ragona, Paola Cassoni, Massimiliano Mistrangelo, Patrizia Racca, Fernando Muñoz and Stefania Martini and has published in prestigious journals such as British Journal of Cancer, British Journal of Radiology and The Journal of Sexual Medicine.

In The Last Decade

Nadia Rondi

17 papers receiving 336 citations

Peers

Nadia Rondi

SURGE

ONCOL

PRM

RADIA

RNMI

Grahame C.W. Howard United Kingdom

Victor Lewitzki Germany

H.-J. Thiel Germany

Serena Detti Italy

Leif Haendler Sweden

Srinath Kotamarti United States

Joanne Nyarangi‐Dix Germany

Josephine Stewart Australia

Vito Lacetera Italy

Shaoqin He China

Grahame C.W. Howard United Kingdom

Nadia Rondi

303 ×1.2

SURGE

141 ×1.0

ONCOL

78 ×0.6

PRM

55 ×1.4

RADIA

22 ×0.8

RNMI

Citations per year, relative to Nadia Rondi Nadia Rondi (= 1×) peers Grahame C.W. Howard

Countries citing papers authored by Nadia Rondi

Since Specialization

Citations

This map shows the geographic impact of Nadia Rondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Rondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Rondi more than expected).

Fields of papers citing papers by Nadia Rondi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Rondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Rondi. The network helps show where Nadia Rondi may publish in the future.

Co-authorship network of co-authors of Nadia Rondi

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Rondi. A scholar is included among the top collaborators of Nadia Rondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Rondi. Nadia Rondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Franco, Pierfrancesco, Francesca Arcadipane, Riccardo Ragona, et al.. (2018). Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation. Cancer Investigation. 36(5). 279–288. 10 indexed citations

2.

Iorio, Giuseppe Carlo, Pierfrancesco Franco, E. Gallio, et al.. (2017). Volumetric modulated arc therapy (VMAT) to deliver nodal irradiation in breast cancer patients. Medical Oncology. 35(1). 1–1. 28 indexed citations

3.

Arcadipane, Francesca, Pierfrancesco Franco, Manuela Ceccarelli, et al.. (2017). Image‐guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer. Asia-Pacific Journal of Clinical Oncology. 14(3). 217–223. 28 indexed citations

4.

Franco, Pierfrancesco, Francesca Arcadipane, Riccardo Ragona, et al.. (2016). Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients. Medical Oncology. 33(7). 72–72. 26 indexed citations

5.

Franco, Pierfrancesco, Riccardo Ragona, Francesca Arcadipane, et al.. (2016). Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer. Clinical & Translational Oncology. 19(1). 67–75. 35 indexed citations

6.

Arcadipane, Francesca, Pierfrancesco Franco, Chiara De‐Colle, et al.. (2016). Hypofractionation with no boost after breast conservation in early-stage breast cancer patients. Medical Oncology. 33(10). 108–108. 8 indexed citations

7.

Franco, Pierfrancesco, Riccardo Ragona, Francesca Arcadipane, et al.. (2016). Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation. Medical Oncology. 33(12). 137–137. 14 indexed citations

8.

Franco, Pierfrancesco, Francesca Arcadipane, Riccardo Ragona, et al.. (2016). Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients. British Journal of Radiology. 89(1060). 20150832–20150832. 37 indexed citations

9.

Franco, Pierfrancesco, Francesca Arcadipane, Riccardo Ragona, et al.. (2016). Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.. PubMed. 36(4). 2027–32. 22 indexed citations

10.

Franco, Pierfrancesco, Francesca Arcadipane, Riccardo Ragona, et al.. (2016). Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.. PubMed. 36(4). 1943–8. 17 indexed citations

11.

Franco, Pierfrancesco, Francesca Arcadipane, Riccardo Ragona, et al.. (2016). Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients. British Journal of Radiology. 89(1060). 20160832–20160832. 7 indexed citations

12.

Franco, Pierfrancesco, Massimiliano Mistrangelo, Francesca Arcadipane, et al.. (2015). Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost Combined with Concurrent Chemotherapy for the Treatment of Anal Cancer Patients: 4-Year Results of a Consecutive Case Series. Cancer Investigation. 33(6). 259–266. 35 indexed citations

13.

Botticella, Angela, Alessia Guarneri, Niccolò Giaj‐Levra, et al.. (2014). Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer. Journal of Cancer Research and Clinical Oncology. 140(7). 1111–1116. 6 indexed citations

14.

Mistrangelo, Massimiliano, M. Bellò, Paola Cassoni, et al.. (2013). Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literature. British Journal of Cancer. 108(3). 527–532. 15 indexed citations

15.

Ricardi, Umberto, Patrizia Racca, Pierfrancesco Franco, et al.. (2013). Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART). Medical Oncology. 30(2). 581–581. 11 indexed citations

16.

Muñoz, Fernando, C. Fiandra, Pierfrancesco Franco, et al.. (2012). Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy. La radiologia medica. 117(6). 1057–1070. 14 indexed citations

17.

Ricardi, Umberto, Paolo Gontero, Patrizia Ciammella, et al.. (2010). Efficacy and Safety of Tadalafil 20 mg on Demand vs. Tadalafil 5 mg Once-a-Day in the Treatment of Post-Radiotherapy Erectile Dysfunction in Prostate Cancer Men: A Randomized Phase II Trial. The Journal of Sexual Medicine. 7(8). 2851–2859. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact